June 14, 2018
You doubtless know that Lyme Disease is a nasty bacterial disease spread by ticks, and which is becoming epidemic in the northern reaches of the U.S. You doubtless also know that there is no vaccine against Lyme Disease.
But that may be about to change.
According to this article at zmescience.com, the French drug manufacturer Valneva has announced that it has successfully completed its first-ever human trial of a vaccine against the disease. The vaccine, which is reportedly up to 96% effective, might soon be available in the UK and US at a “reasonably low” price.
So far, no significant side effects have been reported in the test group, and the company reports that it has poured £262 million ($350 million) into the development of the vaccine, attempting to make it even more effective, and also making sure that it can be manufactured at a reasonable price.
The bad news, alas, is that ticks can transmit other diseases besides Lyme Disease. According to the CDC, that list includes Anaplasmosis, Babesiosis, Borrelia Miyamotoi Disease, Colorado Tick Fever, Ehrlichiosis, Heartland and Bourbon Virus Diseases, Powasson Virus Disease, Rocky Mountain Spotted Fever, Rickettsia parkeri Rickettsiosis, Tickborne Relapsing Fever and Tularemia.
So don’t put away that DEET just yet.